ABSTRACT
Background: Posterior reversible encephalopathy syndrome (PRES) is a benign disorderof reversible subcortical vasogenic cerebral edema. Case characteristics: A 13-yr-old girlpresented 4 days after complete recovery from diabetic ketoacidosis with symptoms ofheadache, altered sensorium, seizures, and visual loss. There was no hypertension orbiochemical abnormalities identified. MRI brain showed hyperintense areas in subcorticaland periventricular white matter of bilateral fronto-parieto-occipetal lobes, with possiblediagnosis of normotensive PRES. Outcome: Full recovery without sequelae, followingneuro-protection and expectant treatment. Message: Identifying PRES in diabeticketoacidosis assists appropriate treatment and prognostication.
ABSTRACT
Objective: To assess the clinical features, prognostic factors and outcome of childhood T-ALL in comparison with B-lineage ALL, treated with a uniform treatment regimen (MCP 841). Setting: Pediatric oncology division of a tertiary care institution in Northern India. Design: Retrospective analysis of clinical data and survival outcome. Participants: 60 children with T-ALL and 139 with Blineage ALL, and less than 15 years of age treated over 15 years. Results: T-ALL was observed in 30%. High risk features at presentation (age 10 years, WBC >50,000/mm3, mediastinal mass, and CNS leukemia) were significantly more frequent in T-ALL as compared to B-lineage ALL (P=0.049, P<0.001, P<0.001 and P=0.02, respectively). Fifty five of 60 T-ALL patients (91.7%) achieved complete remission after induction therapy. There were 3 induction and 10 remission deaths while 11 (18.3%) relapsed. The overall survival and event-free survival of T-lineage ALL (61.5±7.6 and 49.9±7.4, respectively) were similar to that of B-lineage patients (68.7±4.7 and 47.1±5.1, respectively). National Cancer Institute risk groups emerged as significant prognostic factor for event free survival only in B-lineage patients. Conclusions: Even though high risk features were significantly more frequent in T-ALL, survival outcome was similar to that of B-lineage patients. None of the routinely described prognostic parameters significantly impacted survival.
ABSTRACT
Acute lymphoblastic leukemia (ALL) can occasionally relapse in unusual extramedullary sites like bone. Here we present a 6.5-year old boy with 'T' cell ALL who developed a swelling in left tibia which was infiltrated with lymphoblasts 7 months after completion of chemotherapy. Bone marrow and cerebrospinal fluid were negative for blasts. This is the first reported case of bone relapse in ALL from India. We discuss the previous cases of isolated bone relapse in ALL reported in English literature.
Subject(s)
Bone and Bones/pathology , Child, Preschool , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Recurrence , Tibia/pathologyABSTRACT
The authors describe a case of extramedullary relapse in lymph node presenting as lymphoblastic lymphoma seven years following remission of acute lymphoblastic leukemia. To the best of our knowledge, this is the first reported case of an isolated lymph node relapse with hematopoietic remission of leukemia. We have discussed cases of large cell lymphoma and other unusual areas of extramedullary relapse complicating acute lymphoblastic leukemia in hematopoietic remission.